Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors

Details for Australian Patent Application No. 2004273773 (hide)

Owner Jarrow Formulas, Inc.

Inventors Savarino, Andrea

Agent Pizzeys

Pub. Number AU-B-2004273773

PCT Pub. Number WO2005/027855

Priority 60/471,038 16.05.03 US; 60/449,517 21.02.03 US

Filing date 20 February 2004

Wipo publication date 31 March 2005

Acceptance publication date 24 January 2008

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/4725 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2005/027855 Priority application(s): WO2005/027855

24 January 2008 Application Accepted

  Published as AU-B-2004273773

22 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273775-Methods for protection from toxicity of alpha emitting elements during radioimmunotherapy

2004273771-3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)